Therapeutic Intervention of Eriomin Associated with Metformin in the Control of Hyperglycemia in Pre-Diabetic Patients

Plain-language summary

This study examines the effect of a product called Eriomin, combined with Metformin, in controlling high blood sugar (hyperglycemia) in pre-diabetic patients. It enrolled people whose fasting glucose and HbA1c values were in the pre-diabetes range, and participants received either Eriomin or placebo. It is a study with no assigned phase and is currently active but not recruiting new participants (active, not recruiting).

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Active, not recruiting

Sponsor

Thais Cesar

Intervention

Eriomin, Washout, Placebo

Start date

1/15/2024

Estimated completion

12/30/2024

Countries

Brazil

Related genes

Locations

• Botucatú, Brazil

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Glycemia of 6.1 to 7.0 mmol / L
* Glycated hemoglobin with values between 5.7 and 6.4%

Exclusion Criteria:

* use of drugs, vitamins and dietary supplements, alcohol consumption (\> 20 g alcohol/d), and intense physical activity (\> 5 hours/week).
* History of cardiovascular disease, diabetes mellitus, liver, kidney or pancreatic disease